Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Zoltán, Sápi"'
Autor:
Dániel Sztankovics, Ildikó Krencz, Dorottya Moldvai, Titanilla Dankó, Ákos Nagy, Noémi Nagy, Gábor Bedics, András Rókusz, Gergő Papp, Anna-Mária Tőkés, Judit Pápay, Zoltán Sápi, Katalin Dezső, Csaba Bödör, Anna Sebestyén
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Alterations in mTOR signalling molecules, including RICTOR amplification, have been previously described in many cancers, particularly associated with poor prognosis. In this study, RICTOR copy number variation (CNV) results of diagnostic ne
Externí odkaz:
https://doaj.org/article/d916b489a8c1402d8ae70fac8a29c2d2
Autor:
Catherine Cervi, Zoltán Sápi, Gábor Bedics, Erik Zajta, Lajos Hegyi, Judit Pápay, Katalin Dezső, Edit Varga, Katalin Mudra, Csaba Bödör, Monika Csóka
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Significant improvements in the survival rates of paediatric cancer have been achieved over the past decade owing to recent advances in therapeutic and diagnostic strategies. However, disease progression and relapse remain a major challenge for the c
Externí odkaz:
https://doaj.org/article/b616bb309499462a8e79867a9acfbbb7
Autor:
Imre Antal, Zsuzsanna Pápai, Miklós Szendrői, Tamás Perlaky, Katalin Dezső, Zoltán Lippai, Zoltán Sápi
Publikováno v:
Pathology and Oncology Research, Vol 28 (2022)
Due to the relatively high recurrence rate and the destructive nature of the tumor, the treatment of giant cell tumor is still a challenge. Denosumab appeared to be a promising candidate as a therapeutic drug. However, several studies have reported t
Externí odkaz:
https://doaj.org/article/0a1430344c5549fdb46e564fc1264f01
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Diagnostic Pathology, Vol 13, Iss 1, Pp 1-7 (2018)
Abstract Background Synovial sarcoma is a rare soft tissue tumor which contains the unique SS18-SSX1, SS18-SSX2 – or, rarely, SS18-SSX4 - fusion transcripts. It is well known that some soft tissue tumors, like Ewing sarcomas and myxoid liposarcomas
Externí odkaz:
https://doaj.org/article/fcbc02575cdf4669acd04c949b4ff3f6
Publikováno v:
Frontiers in Genetics, Vol 10 (2019)
Coincidences of more than one pathogenic mutation in high and/or moderate risk-associated cancer genes have been rarely reported, and the implication for disease progression has been debated. We present a case harboring two autosomal dominant inherit
Externí odkaz:
https://doaj.org/article/b96fd2954f684c6283a173089810383c
Autor:
Zoltán Lippai, Zoltán Sápi
Publikováno v:
Orvosi Hetilap. 161:1753-1763
Absztrakt: A neurotrofikus tropomiozin receptor-tirozin-kináz (NTRK-) géncsalád tagjai (NTRK1, NTRK2, NTRK3) által kódolt tropomiozin receptor-tirozin-kináz fehérjék (TrkA, TrkB, TrkC) fiziológiásan elsősorban az idegsejtek fejlődéséér
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a16bc1b77c91cf85eb6a129e101c795c
https://doi.org/10.1556/650.2020.31846
https://doi.org/10.1556/650.2020.31846
Publikováno v:
Pathology Oncology Research
Although papillary endothelial hyperplasia may occur at almost any site, one of the most common sites is the hand. It is generally regarded as a reactive vascular proliferation i.e. exuberant form of organizing thrombus. Diagnosis of Masson tumor can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::504a7e5748cbe0d6b7b8a3f140bc3790
http://europepmc.org/articles/PMC7471200
http://europepmc.org/articles/PMC7471200
Publikováno v:
Orvosi Hetilap. 161:232-236
Absztrakt: A pulmonalis arterialis intimalis sarcoma ritka, magas mortalitású daganat, mely lokalizációja miatt a pulmonalis embolia, valamint a tüdőgyulladás tünettanát utánozhatja. A diagnózis felállítása és a megfelelő kezelés kiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de3f1704a6685f25f397467217ef6451
https://doi.org/10.1556/650.2020.31642
https://doi.org/10.1556/650.2020.31642
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0142190 (2015)
BackgroundBevacizumab is an exogenous inhibitor which inhibits the biological activity of human VEGF. Several studies have investigated the effectiveness of bevacizumab therapy according to different cancer types but these days there is an intense de
Externí odkaz:
https://doaj.org/article/9f003625bb7d41469459879e2de7127b